The Motley Fool

I’d buy these 2 FTSE 100 dividend stocks and hold them for the next decade

Image source: Getty Images

If I had to pick two FTSE 100 stocks to buy and hold for the next decade, Croda (LSE: CRDA) and Johnson Matthey (LSE: JMAT) would be high up on my list.

These two companies are both champions in their respective industries and perhaps more importantly, they are both investing hundreds of millions of pounds in staying ahead of the competition.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Investing for the future

Speciality chemicals group Johnson Matthey is the largest secondary platinum group metals refiner in the world, which has both benefits and drawbacks.

The primary benefit, from an investment standpoint, is that the company has a leading position in its industry that is unlikely to be overturned any time soon.

However, the company also has to deal with the volatile prices of palladium and rhodium. This means earnings are volatile too. For example, during the first half of 2019, palladium and rhodium prices jumped by around 50%.

As a result, City analysts are now expecting the group to report a 5% decline in earnings for its current financial year, but a recovery is expected in fiscal 2021. The City is expecting earnings per share of 243p for fiscal 2021, up from 237p for the firm’s 2019 financial year.

What’s more important, in my opinion, is its spending on research and development.

The group invested £100m in research and development during the first half of its 2020 financial year, around 5% of sales. This spending should help the company defend its market share for years to come.

Market leader

Croda is also reinvesting a significant portion of its profits back into the business. The company spent around £100m on research and development in 2018, approximately 7% of group sales.

At first glance, shares in Croda might look expensive, but in my view, the stock is worth its premium valuation.

Indeed, at the time of writing, the shares are dealing at a forward P/E of nearly 26, a five-year high for the group. However, the company is in the top 10% of the most profitable businesses trading on the London market today.

On top of this, the stock has grown earnings at a compound annual rate of 6% over the past six years and the firm also has a record of issuing special dividends to investors.

These metrics tell me that Croda is a highly defensive business and it looks as if it is going to stay that way as the group continues to reinvest profits to drive growth.

The bottom line

Both companies occupy niche sections of their respective markets, and this means that they’re both, to some extent, immune from competition. The sale of speciality chemicals is highly regulated, and customers are not going to change suppliers overnight just because they can get a better price elsewhere.

Put simply, as long as CRDA and JMAT continue to invest in their operations, I think they will remain leaders in their sector for many years to come. That’s why I would buy and hold these stocks for the next decade.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended Croda International. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.